CAS 851199-60-5 Linaclotide Acetate

Send Inquiry
CAS 851199-60-5 Linaclotide Acetate
Details
CAS: 851199-60-5
Product name CAS:851199-60-5:Linaclotide acetate
Sequence Cys-Cys-Glu-Tyr-Cys-Cys-Asn-Pro-Ala-Cys-Thr-Gly-Cys-Tyr (Disulfide bridges: Cys1-Cys6, Cys2-Cys10, Cys5-Cys13)
Three letter sequence H-Cys-Cys-Glu-Tyr-Cys-Cys-Asn-Pro-Ala-Cys-Thr-Gly-Cys-Tyr-OH
Peptide purity (HPLC, %) 95%/98%/99%
Molecular formula C₅₉H₇₉N₁₅O₂₁S₆ (free peptide)
Molecular weight (Da) 1507.73 (free peptide)
Salt form: Acetate
Category
Pharmaceutical Peptides
Share to
Description

Shanghai Sonyt Biotechnology Co., Ltd. is one of the leading manufacturers and suppliers of cas 851199-60-5 linaclotide acetate in China, also supports custom service. Welcome to wholesale bulk high quality cas 851199-60-5 linaclotide acetate from our factory. Contact us for more details.

 

CAS 851199-60-5
Product name CAS:851199-60-5:Linaclotide acetate
Sequence Cys-Cys-Glu-Tyr-Cys-Cys-Asn-Pro-Ala-Cys-Thr-Gly-Cys-Tyr (Disulfide bridges: Cys1-Cys6, Cys2-Cys10, Cys5-Cys13)
Three letter sequence H-Cys-Cys-Glu-Tyr-Cys-Cys-Asn-Pro-Ala-Cys-Thr-Gly-Cys-Tyr-OH
Peptide purity (HPLC, %) 95%/98%/99%
Molecular formula C₅₉H₇₉N₁₅O₂₁S₆ (free peptide)
Molecular weight (Da) 1507.73 (free peptide)
Salt form Acetate

 

Product Basic Information Table

Product Standard English Name Product Abbreviation / Alias Function Tags (comma-separated) Amino Acid Full Name Sequence Molecular Formula Exact Molecular Weight (Da) Average Molecular Weight (Da) N-terminal Modification C-terminal Modification Sequence Length (aa)
Linaclotide acetate Linaclotide acetate; Linzess; Constella; CAS 851199-60-5; GC-C receptor agonist GC-C receptor agonist,Intestinal secretion promotion,IBS-C therapy,Chronic idiopathic constipation research,Gastrointestinal regulatory peptide Cysteine-Cysteine-Glutamic acid-Tyrosine-Cysteine-Cysteine-Asparagine-Proline-Alanine-Cysteine-Threonine-Glycine-Cysteine-Tyrosine (3 disulfide bridges for rigid conformation) C₅₉H₇₉N₁₅O₂₁S₆ (free peptide) 1506.43 1507.73 Free amine, unmodified Free carboxyl, unmodified 14

 

Physicochemical Solubility & Storage Parameters

 

Product Code Appearance Long-term Storage Conditions Short-term Storage Conditions Liquid Stability Solid Powder Stability
PEP-LIN001 white powder Store at -20℃, strictly protected from light, sealed and dry, aliquoted; avoid repeated freeze-thaw cycles and reducing agents Solid powder stable for 2 years sealed and dry at 2-8℃; prepare aqueous solutions freshly before use, aliquots stable for 1 month at -20℃ Stable for 72 h at 4℃; three disulfide bridges are sensitive to reducing agents, high temperature and extreme pH, which cause conformational damage and activity loss Stable for 3 years at -20℃ under dry & dark conditions

 

Functional Description

 

Product Code Frontend Short Summary (for search list display) Detailed Biological Function Description Applicable Research Areas (comma-separated) Targets / Pathways
PEP-LIN001 Selective intestinal epithelial guanylate cyclase C agonist that promotes intestinal fluid secretion and motility, applied in IBS-C and chronic constipation research Linaclotide acetate is a 14-amino acid macrocyclic peptide and selective guanylate cyclase C (GC-C) agonist. Its rigid three-dimensional structure is anchored by three disulfide bonds, enabling high-affinity binding to GC-C receptors on the apical membrane of intestinal epithelial cells. Receptor activation catalyzes intracellular cGMP production, which on one hand promotes chloride and bicarbonate secretion into the intestinal lumen via CFTR channels, increasing intestinal fluid and softening stool; on the other hand, it reduces intestinal sensory nerve sensitivity and relieves abdominal pain. This molecule does not enter the systemic circulation and acts locally in the intestine with very low systemic exposure. Clinically approved for the treatment of adult irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC), it serves as a core tool for gastrointestinal pharmacology, constipation pathogenesis research and peptide gastrointestinal drug development. Gastrointestinal pharmacology research,Irritable bowel syndrome with constipation research,Chronic idiopathic constipation research,Intestinal secretion regulation research,Peptide gastrointestinal drug development Guanylate Cyclase C Receptor (GC-C); cGMP/CFTR signaling pathway; Intestinal epithelial secretion regulatory pathway

Hot Tags: cas 851199-60-5 linaclotide acetate, China cas 851199-60-5 linaclotide acetate manufacturers, suppliers, factory, 129954-34-3, 1566590-77-9, 2381089-83-2, BPC 157, CAS 2381089 83 2, pharmaceutical peptides

Send Inquiry